The process is central to the billing fix that Congress passed last year and that the administration has since been charged with implementing.

Their disagreement centers on whether the U.S. should eventually offer an additional shot to every vaccinated adult.

It’s a sign the drug industry is bending a potential compromise in manufacturers’ favor after spending more than $171 million lobbying in the first half of this year.

Officials said the number of unvaccinated workers in the city is small enough that it shouldn’t cause big disruptions.

The sheer breadth of qualifying medical conditions and occupations, plus the lack of any proof requirements, means just about anyone who got the Pfizer vaccine can now seek out a booster.

The switch comes amid a growing sense of burnout and fatigue within the CDC after almost two years of fighting Covid-19.

The Biden administration last week announced that a third dose of the Pfizer-BioNtech vaccine will be available to parts of the population.

Staff described a summer marked by demands to digest complex data in record time as the government raced to update policies in the face of Delta.